Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences Acquires Li-Cor's Single Molecule Sequencing Technology

NEW YORK (GenomeWeb News) – Pacific Biosciences today said that it has acquired Li-Cor Biosciences’ single molecule sequencing technology, called sequencing by incorporation.
 
The acquisition complements Pacific Bio’s current sequencing technology — SMRT, or single molecule real-time, sequencing method.
 
Li-Cor’s technology identifies nucleotides in a DNA sequence based upon synthesis of a complementary DNA strand. Pacific Bio acquired a number of issued US and foreign patents covering the technology, as well as pending US applications.
 
Menlo Park, Calif.-based Pacific Bio said that Li-Cor has retained rights to intellectual property for sequencing enzymes that were designed for sequencing by polymerase synthesis. It noted that Li-Cor has an active out-licensing program for those enzymes.
 
In addition to the acquisition, Pacific Bio said that the agreement includes ongoing opportunities to collaborate with Li-Cor’s scientists on sequencing enzymes.
 
"Li-Cor's early developments in the field of sequencing by incorporation, as well as their comprehensive intellectual property portfolio surrounding those developments, provide a unique and attractive opportunity for us to combine our resources to build a strong foundation from which to ultimately deliver on the huge advantages of single molecule real time sequencing by synthesis," Hugh Martin, Pacific Biosciences chairman and CEO, said in a statement.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.